Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.68 |
| ▸ | TSHR | P16473 | 4/20 | 0.59 |
| ▸ | NAAA | Q02083 | 1/20 | 0.55 |
| ▸ | CES2 | O00748 | 1/20 | 0.53 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.52 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.47 |
| ▸ | RAD52 | P43351 | 1/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | FAAH | O00519 | 2/20 | 0.46 |
| ▸ | ACHE | P22303 | 3/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Octyl Acetate SCHEMBL4930248 | 1.00 | ALDH1A1 (0.68) | ALDH1A1TSHRNAAACES2EPHX1 | |
| Decylacetate SCHEMBL3426391 | 1.00 | ALDH1A1 (0.68) | ALDH1A1TSHRNAAACES2EPHX1 | |
| Hexyl Acetate SCHEMBL7690856 | 1.00 | ALDH1A1 (0.68) | ALDH1A1TSHRNAAACES2EPHX1 | |
| Tetradecylacetate SCHEMBL537712 | 1.00 | ALDH1A1 (0.68) | ALDH1A1TSHRNAAACES2EPHX1 | |
| Tridecylacetate SCHEMBL2400935 | 1.00 | ALDH1A1 (0.68) | ALDH1A1TSHRNAAACES2EPHX1 | |
| Ether SCHEMBL4931894 | 1.00 | ALDH1A1 (0.68) | ALDH1A1TSHRNAAACES2EPHX1 | |
| Dodecylacetate SCHEMBL353028 | 1.00 | ALDH1A1 (0.68) | ALDH1A1TSHRNAAACES2EPHX1 | |
| Octyl Acetate SCHEMBL9751176 | 0.98 | ALDH1A1 (0.65) | ALDH1A1TSHRNAAACES2EPHX1 | |
| Decylacetate SCHEMBL22091864 | 0.98 | ALDH1A1 (0.65) | ALDH1A1TSHRNAAACES2EPHX1 | |
| Dodecylacetate SCHEMBL515330 | 0.98 | ALDH1A1 (0.65) | ALDH1A1TSHRNAAACES2EPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 83 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3443951-B1 | SUPERFATTING AGENT AND PERSONAL CARE COMPOSITION | SABO SPA (IT) | 2022-09-21 | — | — | EP | disclosed |
| CN-108883049-B | Superfatting agents and personal care compositions | 萨博公司 | 2021-03-12 | — | — | CN | disclosed |
| EP-3443951-A1 | SUPERFATTING AGENT AND PERSONAL CARE COMPOSITION | Sabo S.p.A. (IT) | 2019-02-20 | — | — | EP | disclosed |
| EP-1799631-B1 | HYDROXYCITRIC ACID DERIVATIVES AND SKIN EXTERNAL PREPARATIONS CONTAINING THE SAME | SHOWA DENKO KK (JP) | 2017-01-25 | — | — | EP | disclosed |
| EP-2642975-B1 | SKIN EXTERNAL PREPARATION AND METHOD OF PRODUCING SAME | SHOWA DENKO KK (JP) | 2016-08-24 | — | — | EP | disclosed |
| EP-2248511-B1 | HAIR WASHING COMPOSITION | KAO CORP (JP) | 2015-11-25 | — | — | EP | disclosed |
| US-9180079-B2 | Skin external preparation and method of producing same | SHOWA DENKO K.K. (JP) | 2015-11-10 | — | — | US | disclosed |
| US-8741825-B2 | Hair washing composition | KAO CORPORATION (JP) | 2014-06-03 | — | — | US | disclosed |
| EP-1928402-B1 | Carnitine derivative, salt thereof, external skin preparation and cosmetic preparation | SHOWA DENKO KK (JP) | 2014-03-12 | — | — | EP | disclosed |
| US-20130287718-A1 | SKIN EXTERNAL PREPARATION AND METHOD OF PRODUCING SAME | SHOWA DENKO K.K. (JP) | 2013-10-31 | — | — | US | disclosed |
| WO-2005102267-A1 | AGENT FOR SKIN EXTERNAL USE CONTAINING TOCOPHEROL DERIVATIVE, ASCORBIC ACID DERIVATIVE AND SURFACE ACTIVE AGENT HAVING LIPOPEPTIDE STRUCTURE | SHOWA DENKO K.K. (JP) | 2005-11-03 | — | — | WO | disclosed |
| WO-2005094777-A1 | EXTERNAL PREPARATION FOR SKIN | SHOWA DENKO K.K. (JP) | 2005-10-13 | — | — | WO | disclosed |
| WO-2005095462-A1 | MOISTURE RETENTION POLYMER COMPOUND | SHOWA DENKO K.K. (JP) | 2005-10-13 | — | — | WO | disclosed |
| US-20050220744-A1 | Polysaccharide/functional compound complex | SHOWA DENKO K.K. | 2005-10-06 | — | — | US | disclosed |
| WO-2005092285-A1 | A SKIN CARE AND COSMETIC PREPARATION CONTAINING AN INOSITOL DERIVATIVE | SHOWA DENKO K.K. (JP) | 2005-10-06 | — | — | WO | disclosed |
| WO-2005089708-A1 | OIL-IN-WATER EMULSIFIED COMPOSITION, AND EXTERNAL PREPARATION FOR SKIN AND COSMETICS USING THE COMPOSITION | SHOWA DENKO K.K. (JP) | 2005-09-29 | — | — | WO | disclosed |
| WO-2005074881-A2 | METHOD FOR STABILIZING OIL-BASED THICKENING GEL COMPOSITION | SHOWA DENKO K.K. (JP) | 2005-08-18 | — | — | WO | disclosed |
| WO-2005034903-A1 | AGENT FOR SKIN EXTERNAL USE CONTAINING SALT OF ASCORBIC ACID DERIVATIVE, METHOD FOR STABILIZING THE AGENT FOR SKIN EXTERNAL USE, AND STABILIZER | SHOWA DENKO K.K. (JP) | 2005-04-21 | — | — | WO | disclosed |
| WO-2005020950-A1 | COSMETIC COMPOSITION COMPRISING A AND A LIPOPEPTIDE | SHOWA DENKO K.K. (JP) | 2005-03-10 | — | — | WO | disclosed |
| US-20040210077-A1 | Monocarboxylic acid esters of propoxylated fatty alcohols as pigment dispersants | CRODA, INC. | 2004-10-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130287718-A1 | SKIN EXTERNAL PREPARATION AND METHOD OF PRODUCING SAME | RBP4, RBP1, PROC | ALDH1A1 643/4885TSHR 4481/4885NAAA 2191/4885 |
| US-20040210077-A1 | Monocarboxylic acid esters of propoxylated fatty alcohols as pigment dispersants | MITF, ELOVL5, ADH5 | ALDH1A1 108/4885TSHR 4215/4885NAAA 3727/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.